Results from a national study led by UC San Francisco informed the first guidelines at the federal level in the U.S. to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.
Cancer Center member Bridget Keenan, MD, PhD, reflects on being among the first two physician-scientists to complete the two-year curriculum of the HDFCCC K12 Physician Scientist Program in Clinical Oncology (PSPCO).
UCSF Medical Center has again been named as one of the country’s top hospitals for patient care and safety, appearing on the national Honor Roll in U.S. News & World Report’s Best Hospitals rankings for 2024-2025.
This month marked an important milestone for UCSF faculty and clinicians working to take on the challenge of glioblastoma multiforme (GBM). They treated their first patient with a promising chimeric antigen receptor (CAR) T-cell therapy that was fully conceived, designed, optimized and manufactured here at UCSF.
The Cancer Center’s Office of Diversity, Equity, Inclusion, and Accessibility (DEIA) has awarded a new round of grants to support career development activities for faculty, staff, and trainees across the UCSF cancer community.
Eating more fruits, nuts, and vegetables each day – along with fewer animal products – is associated with a nearly 50% reduction in the risk of prostate cancer progression.
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s annual meeting of the American Association for Cancer Research (AACR) conference.